78 related articles for article (PubMed ID: 17456056)
1. Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
Lietz A; Janz M; Sigvardsson M; Jundt F; Dörken B; Mathas S
Br J Haematol; 2007 May; 137(4):342-8. PubMed ID: 17456056
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
Mathas S; Janz M; Hummel F; Hummel M; Wollert-Wulf B; Lusatis S; Anagnostopoulos I; Lietz A; Sigvardsson M; Jundt F; Jöhrens K; Bommert K; Stein H; Dörken B
Nat Immunol; 2006 Feb; 7(2):207-15. PubMed ID: 16369535
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.
Renné C; Martin-Subero JI; Eickernjäger M; Hansmann ML; Küppers R; Siebert R; Bräuninger A
Am J Pathol; 2006 Aug; 169(2):655-64. PubMed ID: 16877363
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
5. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12.
Kee BL; Murre C
J Exp Med; 1998 Aug; 188(4):699-713. PubMed ID: 9705952
[TBL] [Abstract][Full Text] [Related]
6. Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development.
Kwon K; Hutter C; Sun Q; Bilic I; Cobaleda C; Malin S; Busslinger M
Immunity; 2008 Jun; 28(6):751-62. PubMed ID: 18538592
[TBL] [Abstract][Full Text] [Related]
7. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
O'Riordan M; Grosschedl R
Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
[TBL] [Abstract][Full Text] [Related]
8. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
[TBL] [Abstract][Full Text] [Related]
9. Immunologic regulation of bone development.
Horowitz MC; Lorenzo JA
Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387
[TBL] [Abstract][Full Text] [Related]
10. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A.
Seet CS; Brumbaugh RL; Kee BL
J Exp Med; 2004 Jun; 199(12):1689-700. PubMed ID: 15210745
[TBL] [Abstract][Full Text] [Related]
11. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.
Hodawadekar S; Yu D; Cozma D; Freedman B; Sunyer O; Atchison ML; Thomas-Tikhonenko A
Exp Cell Res; 2007 Jan; 313(2):331-40. PubMed ID: 17098231
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of B lymphoid cells in human lymphoma pathogenesis.
Janz M; Dörken B; Mathas S
Cell Cycle; 2006 May; 5(10):1057-61. PubMed ID: 16687930
[TBL] [Abstract][Full Text] [Related]
13. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.
Jundt F; Acikgöz O; Kwon SH; Schwarzer R; Anagnostopoulos I; Wiesner B; Mathas S; Hummel M; Stein H; Reichardt HM; Dörken B
Leukemia; 2008 Aug; 22(8):1587-94. PubMed ID: 18449208
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
[TBL] [Abstract][Full Text] [Related]
16. Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton's lymphoma.
Bharti B; Mishra R
Biochim Biophys Acta; 2011 Dec; 1813(12):2071-8. PubMed ID: 21854813
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of biphenotypic, bigenotypic mature lymphoma.
Koletsa T; Kotoula V; Christoforidou A; Pantelidou P; Petrakis G; Tsatalas C; Kostopoulos I
J Clin Pathol; 2013 Dec; 66(12):1090-2. PubMed ID: 23794479
[No Abstract] [Full Text] [Related]
18. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
Rolink AG; Nutt SL; Melchers F; Busslinger M
Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus.
Walter K; Bonifer C; Tagoh H
Blood; 2008 Sep; 112(5):1673-82. PubMed ID: 18552207
[TBL] [Abstract][Full Text] [Related]
20. Early B-cell factor 1 regulates the expansion of B-cell progenitors in a dose-dependent manner.
Åhsberg J; Ungerbäck J; Strid T; Welinder E; Stjernberg J; Larsson M; Qian H; Sigvardsson M
J Biol Chem; 2013 Nov; 288(46):33449-61. PubMed ID: 24078629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
